[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ExelixisInc Exelixis Exelixis posts on X about $exel, checkpoint the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::206746746/interactions)  - X Week XXX +8,111% - X Month XXXXX +530% - X Months XXXXX -XX% - X Year XXXXX -XX% ### Mentions: X [#](/creator/twitter::206746746/posts_active)  - X Week X +200% - X Month X +400% - X Months XX -XX% - X Year XX -XX% ### Followers: XXXXX [#](/creator/twitter::206746746/followers)  - X Week XXXXX no change - X Month XXXXX -XXXX% - X Months XXXXX -XXXX% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::206746746/influencer_rank)  ### Social Influence [#](/creator/twitter::206746746/influence) --- **Social topic influence** [$exel](/topic/$exel) #12, [checkpoint](/topic/checkpoint) **Top assets mentioned** [Exelixis Inc (EXEL)](/topic/$exel) ### Top Social Posts [#](/creator/twitter::206746746/posts) --- Top posts by engagements in the last XX hours "Just announced: Detailed results from the phase X pivotal trial of $EXEL novel oral kinase inhibitor in combination with an immune checkpoint inhibitor in metastatic #ColorectalCancer presented at #ESMO25 and published in @TheLancet. Learn more:" [X Link](https://x.com/ExelixisInc/status/1980164589519319538) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-20T06:50Z 5660 followers, XXX engagements "See results from a subgroup analysis of the phase X pivotal trial evaluating $EXEL flagship therapy in patients with advanced #NeuroendocrineTumors (NET) at #ESMO25. Learn more:" [X Link](https://x.com/ExelixisInc/status/1979443962315264169) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-18T07:06Z 5657 followers, XXX engagements "ATTN $EXEL Investors: Q3 earnings webcast coming soon. Details:" [X Link](https://x.com/ExelixisInc/status/1980729819727122868) [@ExelixisInc](/creator/x/ExelixisInc) 2025-10-21T20:16Z 5658 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ExelixisInc ExelixisExelixis posts on X about $exel, checkpoint the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social topic influence $exel #12, checkpoint
Top assets mentioned Exelixis Inc (EXEL)
Top posts by engagements in the last XX hours
"Just announced: Detailed results from the phase X pivotal trial of $EXEL novel oral kinase inhibitor in combination with an immune checkpoint inhibitor in metastatic #ColorectalCancer presented at #ESMO25 and published in @TheLancet. Learn more:"
X Link @ExelixisInc 2025-10-20T06:50Z 5660 followers, XXX engagements
"See results from a subgroup analysis of the phase X pivotal trial evaluating $EXEL flagship therapy in patients with advanced #NeuroendocrineTumors (NET) at #ESMO25. Learn more:"
X Link @ExelixisInc 2025-10-18T07:06Z 5657 followers, XXX engagements
"ATTN $EXEL Investors: Q3 earnings webcast coming soon. Details:"
X Link @ExelixisInc 2025-10-21T20:16Z 5658 followers, XXX engagements
/creator/twitter::ExelixisInc